99 related articles for article (PubMed ID: 2959074)
1. Effect of rioprostil (16-methyl-prostaglandin-E1 analog) on gastric secretion in healthy volunteers.
Vaona B; Vantini I; Benini L; Brocco G; Chiarioni G; Scuro LA
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():328-33. PubMed ID: 2959074
[No Abstract] [Full Text] [Related]
2. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1.
Demol P; Wingender W; Weihrauch TR; Graefe KH
Arzneimittelforschung; 1985; 35(5):861-3. PubMed ID: 3927929
[TBL] [Abstract][Full Text] [Related]
3. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
Guslandi M; Passaretti S; Tittobello A; Fasani R
Clin Ther; 1986; 8(6):619-23. PubMed ID: 3098425
[TBL] [Abstract][Full Text] [Related]
4. Effect of rioprostil, an oral prostaglandin E1 (PGE1) analogue, on lower esophageal sphincter pressure and on the motility of the distal esophagus in healthy volunteers.
Baunack AR; Froese G; Demol P; Wargenau M; Ruoff HJ; Weihrauch TR
Z Gastroenterol; 1988 Apr; 26(4):199-203. PubMed ID: 3149082
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin-stimulated gastric mucus secretion in man.
Domschke W; Domschke S; Hornig D; Demling L
Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):292-4. PubMed ID: 358722
[TBL] [Abstract][Full Text] [Related]
6. Effect of 16, 16-dimethyl prostaglandin E2 methyl ester on gastric secretion induced by pentagastrin and pepton meal in man.
Swierczek J; Kwiecień N; Oleksy J; Konturek SJ
Acta Physiol Pol; 1976; 27(2):131-8. PubMed ID: 775888
[TBL] [Abstract][Full Text] [Related]
7. The effects of rioprostil on gastric emptying and intragastric acidity.
Penston JG; Johnston DA; Wormsley KG
Hepatogastroenterology; 1986 Jun; 33(3):120-2. PubMed ID: 3091468
[TBL] [Abstract][Full Text] [Related]
8. [Rioprostil 600 micrograms at night: marked inhibition of nocturnal intragastric acidity in man].
Dammann HG; Rehner M; Walter TA; Müller P; Simon B
Z Gastroenterol; 1986 May; 24(5):245-9. PubMed ID: 3088858
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nocturnal gastric secretion in normal human volunteers by misoprostol: a synthetic prostaglandin E1 methyl ester analog.
Akdamar K; Agrawal N; Ertan A
Am J Gastroenterol; 1982 Dec; 77(12):902-4. PubMed ID: 6816064
[TBL] [Abstract][Full Text] [Related]
10. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
11. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
Demol P; Schmitz HD; Weihrauch TR; Kuhlmann J
Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
[TBL] [Abstract][Full Text] [Related]
12. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
[TBL] [Abstract][Full Text] [Related]
13. Rioprostil: a clinical experience in gastric ulcer treatment.
Mascio G; Guida L; Mascio MV; Maggiolo F
Int J Clin Pharmacol Res; 1988; 8(5):341-4. PubMed ID: 3147950
[TBL] [Abstract][Full Text] [Related]
14. Effect of rioprostil, a synthetic prostaglandin E1 on meal-stimulated gastric acid secretion and plasma gastrin levels in humans.
Schulte K; Singer MV; Eysselein V; Demol P; Goebell H
Digestion; 1987; 36(3):162-7. PubMed ID: 3109990
[TBL] [Abstract][Full Text] [Related]
15. Effect of rioprostil, a methyl-prostaglandin E1, on plasma level and renal excretion of beta-acetyldigoxin.
Demol P; Wingender W; Kuhlmann J
Scand J Gastroenterol Suppl; 1989; 164():68-71; discussion 71-2. PubMed ID: 2510284
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
[TBL] [Abstract][Full Text] [Related]
17. Rioprostil 600 micrograms nocte: high duodenal ulcer healing rates and low incidence of side effects.
Dammann HG; Walter TA; Müller P; Simon B
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():303-6. PubMed ID: 2959068
[No Abstract] [Full Text] [Related]
18. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing.
Simon B; Dammann HG; Müller P
Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657
[TBL] [Abstract][Full Text] [Related]
19. Rioprostil, a new prostaglandin E1 analogue does not affect glucose homeostasis in healthy volunteers.
Eichler HG; Korn A; Businger JA; Waldhäusl WK
Arch Int Pharmacodyn Ther; 1989; 298():288-92. PubMed ID: 2502955
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of gastric secretion by a new H2-antagonist, YM-11170 in healthy subjects.
Miwa M; Tani N; Miwa T
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):214-7. PubMed ID: 6325352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
